Company · CIK 0001302573 · SIC 2834 — Pharmaceutical Preparations
OncoMed Pharmaceuticals Inc · OMED
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2018 SForm 4 → | Dec 26, 4:35 pm EST | Austin GurneySee Remarks | 11,117 | $0.5999 | $6,669 | 66,807 | −14.3% | plan? |
| Oct 10, 2018 SForm 4 → | Oct 11, 7:00 pm EDT | Robert StaggSVP, Clinical R&D | 927 | $2.01 | $1,863 | 40,670 | −2.23% | plan? |
| Oct 10, 2018 SForm 4 → | Oct 11, 6:59 pm EDT | Yvonne LiSee Remarks | 927 | $2.02 | $1,873 | 59,734 | −1.53% | plan? |
| Oct 10, 2018 SForm 4 → | Oct 11, 6:57 pm EDT | Austin GurneySee Remarks | 1,156 | $2.01 | $2,324 | 77,924 | −1.46% | plan? |
| Oct 10, 2018 SForm 4 → | Oct 11, 6:56 pm EDT | Alicia J. HagerSVP & General Counsel | 1,156 | $2.02 | $2,335 | 51,754 | −2.18% | plan? |
| Oct 10, 2018 SForm 4 → | Oct 11, 6:55 pm EDT | John A. LewickiPresident & CEO, Director | 1,156 | $2.01 | $2,324 | 55,966 | −2.02% | plan? |
| Oct 9, 2018 SForm 4 → | Oct 10, 7:44 pm EDT | Yvonne LiSee Remarks | 1,229 | $2.13 | $2,616 | 60,661 | −1.99% | plan? |
| Oct 9, 2018 SForm 4 → | Oct 10, 7:42 pm EDT | Austin GurneySee Remarks | 1,686 | $2.13 | $3,589 | 79,080 | −2.09% | plan? |
| Oct 9, 2018 SForm 4 → | Oct 10, 7:41 pm EDT | Robert StaggSVP, Clinical R&D | 1,686 | $2.13 | $3,589 | 41,597 | −3.90% | plan? |
| Oct 9, 2018 SForm 4 → | Oct 10, 7:40 pm EDT | John A. LewickiPresident & CEO, Director | 2,296 | $2.13 | $4,888 | 57,122 | −3.86% | plan? |
| Oct 9, 2018 SForm 4 → | Oct 10, 7:38 pm EDT | Alicia J. HagerSVP & General Counsel | 1,686 | $2.13 | $3,589 | 52,910 | −3.09% | plan? |
| Aug 6, 2018 GForm 5 → | Feb 13, 2019, 7:51 pm EST | John A. LewickiPresident & CEO, Director | 23,586 | — | — | 111,181 | — | plan? |
| Apr 24, 2018 SForm 4 → | Apr 26, 6:14 pm EDT | Yvonne LiSee Remarks | 5,062 | $2.68 | $13,555 | 59,890 | −7.79% | plan? |
| Apr 24, 2018 SForm 4 → | Apr 26, 6:13 pm EDT | Robert StaggSVP, Clinical R&D | 4,051 | $2.68 | $10,848 | 43,283 | −8.56% | plan? |
| Apr 24, 2018 SForm 4 → | Apr 26, 6:13 pm EDT | John A. LewickiPresident & CEO, Director | 4,557 | $2.68 | $12,202 | 55,418 | −7.60% | plan? |
| Apr 24, 2018 SForm 4 → | Apr 26, 6:12 pm EDT | Austin GurneySee Remarks | 4,051 | $2.68 | $10,848 | 76,766 | −5.01% | plan? |
| Apr 24, 2018 SForm 4 → | Apr 26, 6:11 pm EDT | Alicia J. HagerSVP & General Counsel | 4,051 | $2.68 | $10,848 | 54,596 | −6.91% | plan? |
| Feb 26, 2018 AForm 4 → | Feb 28, 4:45 pm EST | Perry A KarsenDirector | 70,500 | — | — | 80,500 | — | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 6:36 pm EDT | Sunil PatelSee Remarks | 1,248 | $4.24 | $5,295 | 68,336 | −1.79% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 6:35 pm EDT | Paul J HastingsChairman & CEO | 1,398 | $4.24 | $5,931 | 76,188 | −1.80% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 6:35 pm EDT | John A. LewickiEVP, Research & Development | 1,248 | $4.24 | $5,295 | 70,412 | −1.74% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 6:34 pm EDT | Austin GurneySee Remarks | 1,248 | $4.24 | $5,295 | 80,817 | −1.52% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 6:33 pm EDT | Alicia J. HagerSVP & General Counsel | 1,248 | $4.24 | $5,295 | 58,647 | −2.08% | plan? |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:28 pm EDT | Sunil PatelSee Remarks | 25,000 | — | — | 69,584 | — | plan? |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:28 pm EDT | John A. LewickiEVP, Research & Development | 25,000 | — | — | 71,660 | — | plan? |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:27 pm EDT | Alicia J. HagerSVP & General Counsel | 18,334 | — | — | 59,895 | — | plan? |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:27 pm EDT | Austin GurneySee Remarks | 18,334 | — | — | 82,065 | — | plan? |
| Jun 5, 2017 PForm 4 → | Jun 7, 6:18 pm EDT | Perry A KarsenDirector | 10,000 | $3.46 | $34,588 | 10,000 | — | plan? |
| May 25, 2017 PForm 4 → | May 26, 5:51 pm EDT | Jack W LasersohnDirector | 34,614 | $3.37 | $116,639 | 185,709 | +22.9% | plan? |
| May 24, 2017 SForm 4 → | May 26, 11:57 am EDT | Jonathan D RootDirector | 13,880 | $3.71 | $51,441 | 0 | −100% | plan? |
| May 23, 2017 PForm 4 → | May 25, 6:33 pm EDT | Jack W LasersohnDirector | 20,000 | $3.55 | $71,000 | 151,095 | +15.3% | plan? |
| May 19, 2017 SForm 4 → | May 22, 8:16 pm EDT | Jonathan D RootDirector | 7,487 | $3.70 | $27,712 | 4,669 | −61.6% | plan? |
| May 16, 2017 PForm 4 → | May 18, 6:43 pm EDT | Jack W LasersohnDirector | 23,507 | $3.49 | $82,061 | 131,095 | +21.8% | plan? |
| May 16, 2017 SForm 4 → | May 18, 4:49 pm EDT | Jonathan D RootDirector | 6,900 | $3.58 | $24,714 | 7,188 | −49.0% | plan? |
| May 11, 2017 JForm 4 → | May 15, 6:42 pm EDT | Jonathan D RootDirector | 2,065,927 | — | — | 0 | — | plan? |
| May 10, 2017 GForm 5 → | Feb 6, 2018, 7:57 pm EST | John A. LewickiPresident | 20,874 | — | — | 99,388 | — | plan? |
| Apr 24, 2017 AForm 4 → | Apr 25, 6:12 pm EDT | Paul J HastingsChairman & CEO, Director | 45,000 | — | — | 77,586 | — | plan? |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:13 pm EDT | Timothy HoeySVP, Cancer Biology & Co-CSO | 20,000 | — | — | 77,225 | — | plan? |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:12 pm EDT | Sunil PatelSee Remarks | 20,000 | — | — | 44,584 | — | plan? |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:11 pm EDT | John A. LewickiEVP, Research & Development | 22,500 | — | — | 45,437 | — | plan? |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:10 pm EDT | Austin GurneySee Remarks | 20,000 | — | — | 63,301 | — | plan? |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:09 pm EDT | Alicia J. HagerSVP & General Counsel | 20,000 | — | — | 41,561 | — | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:56 pm EDT | John A. LewickiEVP, Research & Development | 5,754 | $9.06 | $52,113 | 22,937 | −20.1% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:41 pm EDT | Austin GurneySee Remarks | 5,754 | $9.06 | $52,113 | 43,301 | −11.7% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:40 pm EDT | Sunil PatelSee Remarks | 5,754 | $9.06 | $52,113 | 24,584 | −19.0% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:40 pm EDT | Timothy HoeySVP, Cancer Biology & Co-CSO | 5,754 | $9.06 | $52,113 | 57,225 | −9.14% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:39 pm EDT | Alicia J. HagerSVP & General Counsel | 4,316 | $9.06 | $39,089 | 21,561 | −16.7% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 5, 7:38 pm EDT | Paul J HastingsChairman & CEO, Director | 6,473 | $9.06 | $58,625 | 32,586 | −16.6% | plan? |
| Mar 15, 2017 SForm 4 → | Mar 17, 5:57 pm EDT | Alicia J. HagerSVP & General Counsel | 6,652 | $10.00 | $66,520 | 25,877 | −20.4% | plan? |
| Mar 15, 2017 MForm 4 → | Mar 17, 5:57 pm EDT | Alicia J. HagerSVP & General Counsel | 6,652 | $3.42 | $22,750 | 32,529 | — | plan? |
| Jan 10, 2017 JForm 4 → | Jan 11, 8:40 pm EST | Jack W LasersohnDirector | 444,433 | — | — | 380,299 | — | plan? |
| Jan 5, 2017 SForm 4 → | Jan 9, 5:55 pm EST | Paul J HastingsChairman & CEO, Director | 42,738 | $8.34 | $356,559 | 37,323 | −53.4% | plan? |
| Jan 5, 2017 MForm 4 → | Jan 9, 5:55 pm EST | Paul J HastingsChairman & CEO, Director | 42,738 | $1.43 | $61,115 | 58,692 | — | plan? |
| Jan 3, 2017 SForm 4 → | Jan 5, 7:11 pm EST | John A. LewickiEVP, Research & Development | 9,175 | $7.63 | $70,045 | 31,636 | −22.5% | plan? |
| Jan 3, 2017 MForm 4 → | Jan 5, 7:11 pm EST | John A. LewickiEVP, Research & Development | 9,175 | $1.43 | $13,120 | 40,811 | — | plan? |
| Jan 3, 2017 SForm 4 → | Jan 5, 7:07 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 12,763 | $7.64 | $97,448 | 60,979 | −17.3% | plan? |
| Jan 3, 2017 MForm 4 → | Jan 5, 7:07 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 12,763 | $1.43 | $18,251 | 73,742 | — | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:21 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 12,500 | $9.89 | $123,609 | 60,979 | −17.0% | plan? |
| Nov 16, 2016 MForm 4 → | Nov 18, 6:21 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 12,500 | $1.43 | $17,875 | 73,479 | — | plan? |
| Oct 10, 2016 JForm 4 → | Oct 12, 8:22 pm EDT | Jack W LasersohnDirector | 4,109 | — | — | 489,109 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:44 pm EDT | John A. LewickiEVP, Research & Development | 12,500 | — | — | 31,636 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:43 pm EDT | Timothy HoeySVP & Co-CSO | 12,500 | — | — | 60,979 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:43 pm EDT | Paul J HastingsChairman & CEO, Director | 14,000 | — | — | 37,323 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:42 pm EDT | Austin GurneySVP & Co-CSO | 12,500 | — | — | 47,055 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:42 pm EDT | Jakob DupontSVP & Chief Medical Officer | 12,500 | — | — | 34,440 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:41 pm EDT | Sunil PatelSee Remarks | 12,500 | — | — | 30,338 | — | plan? |
| Oct 9, 2016 AForm 4 → | Oct 11, 9:41 pm EDT | Alicia J. HagerVP & General Counsel | 12,500 | — | — | 25,877 | — | plan? |
| Mar 17, 2016 JForm 4 → | Mar 21, 6:37 pm EDT | Jack W LasersohnDirector | 444,489 | — | — | 488,287 | — | plan? |
| Jan 11, 2016 SForm 4 → | Jan 12, 5:38 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $20.01 | $50,021 | 20,642 | −10.8% | plan? |
| Jan 11, 2016 MForm 4 → | Jan 12, 5:38 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $4.56 | $11,400 | 23,142 | — | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:27 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,162 | $22.28 | $48,160 | 20,642 | −9.48% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:26 pm EST | Austin GurneySee Remarks | 2,162 | $22.28 | $48,160 | 33,257 | −6.10% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:26 pm EST | Timothy HoeySVP, Cancer Biology | 2,162 | $22.28 | $48,162 | 47,181 | −4.38% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:25 pm EST | Paul J HastingsChairman & CEO, Director | 2,412 | $22.28 | $53,731 | 22,025 | −9.87% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:25 pm EST | Alicia J. HagerVP & General Counsel | 1,623 | $22.28 | $36,153 | 13,377 | −10.8% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:24 pm EST | Sunil PatelSee Remarks | 2,162 | $22.28 | $48,168 | 17,838 | −10.8% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 8, 7:24 pm EST | John A. LewickiEVP & Chief Scientific Officer | 2,162 | $22.28 | $48,162 | 17,838 | −10.8% | plan? |
| Dec 10, 2015 SForm 4 → | Dec 14, 5:02 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $20.49 | $51,231 | 22,804 | −9.88% | plan? |
| Dec 10, 2015 MForm 4 → | Dec 14, 5:02 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $4.56 | $11,400 | 25,304 | — | plan? |
| Nov 30, 2015 JForm 4 → | Dec 2, 6:53 pm EST | Laurence LaskyDirector | 7,433 | — | — | 10,332 | — | plan? |
| Nov 30, 2015 JForm 4 → | Dec 2, 5:09 pm EST | Terry P GouldDirector | 176,078 | — | — | 59,567 | — | plan? |
| Nov 30, 2015 JForm 4 → | Dec 2, 5:09 pm EST | Jonathan D RootDirector | 429 | — | — | 65,091 | — | plan? |
| Nov 30, 2015 JForm 4 → | Dec 2, 5:07 pm EST | Jack W LasersohnDirector | 71,282 | — | — | 597,127 | — | plan? |
| Nov 27, 2015 SForm 4 → | Dec 1, 5:19 pm EST | Alicia J. HagerVP & General Counsel | 1,800 | $23.14 | $41,654 | 15,000 | −10.7% | plan? |
| Nov 27, 2015 MForm 4 → | Dec 1, 5:19 pm EST | Alicia J. HagerVP & General Counsel | 1,800 | $3.42 | $6,156 | 16,800 | — | plan? |
| Nov 10, 2015 SForm 4 → | Nov 12, 6:48 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $21.17 | $52,923 | 22,804 | −9.88% | plan? |
| Nov 10, 2015 MForm 4 → | Nov 12, 6:48 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | $4.56 | $11,400 | 25,304 | — | plan? |
| Oct 27, 2015 SForm 4 → | Oct 29, 7:49 pm EDT | Alicia J. HagerVP & General Counsel | 5,400 | $21.00 | $113,400 | 15,000 | −26.5% | plan? |
| Oct 27, 2015 MForm 4 → | Oct 29, 7:49 pm EDT | Alicia J. HagerVP & General Counsel | 5,400 | $3.42 | $18,468 | 20,400 | — | plan? |
| Oct 26, 2015 SForm 4 → | Oct 27, 7:15 pm EDT | Austin GurneySee Remarks | 14,000 | $20.00 | $280,000 | 35,419 | −28.3% | plan? |
| Oct 26, 2015 SForm 4 → | Oct 27, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 5,000 | $20.00 | $100,000 | 22,804 | −18.0% | plan? |
| Oct 26, 2015 MForm 4 → | Oct 27, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 5,000 | $4.56 | $22,800 | 27,804 | — | plan? |
| Sep 30, 2015 PForm 4 → | Oct 1, 7:39 pm EDT | Jack W LasersohnDirector | 11,210 | $16.01 | $179,512 | 46,560 | +31.7% | plan? |
| Sep 28, 2015 PForm 4 → | Sep 30, 7:54 pm EDT | Jack W LasersohnDirector | 13,140 | $14.60 | $191,784 | 35,350 | +59.2% | plan? |
| Aug 10, 2015 SForm 4 → | Aug 12, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | $22.25 | $55,622 | 22,377 | −10.0% | plan? |
| Aug 10, 2015 MForm 4 → | Aug 12, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | $4.56 | $11,400 | 24,877 | — | plan? |
| Jul 29, 2015 SForm 4 → | Jul 31, 4:21 pm EDT | Austin GurneySee Remarks | 14,000 | $20.88 | $292,359 | 49,419 | −22.1% | plan? |
| Jul 28, 2015 SForm 4 → | Jul 29, 4:57 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | $21.00 | $37,800 | 15,000 | −10.7% | plan? |
| Jul 28, 2015 MForm 4 → | Jul 29, 4:57 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | $3.42 | $6,156 | 16,800 | — | plan? |
| Jul 10, 2015 SForm 4 → | Jul 13, 5:28 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | $20.13 | $50,325 | 22,377 | −10.0% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2018 AForm 4 → | Jun 25, 6:11 pm EDT | Michael S WyzgaDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:10 pm EDT | Deepika PakianathanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:09 pm EDT | Denise Pollard-KnightDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:09 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:08 pm EDT | Jack W LasersohnDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:07 pm EDT | Jonathan D RootDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 25, 6:07 pm EDT | Rick E WinninghamDirector | 15,000 | — | — | 15,000 | — | |
| Mar 18, 2018 AForm 4 → | Mar 20, 5:28 pm EDT | Yvonne LiSee Remarks | 75,000 | — | — | 75,000 | — | |
| Mar 16, 2018 AForm 4 → | Mar 19, 6:42 pm EDT | John A. LewickiPresident & CEO | 125,000 | — | — | 125,000 | — | |
| Feb 26, 2018 AForm 4 → | Feb 28, 4:45 pm EST | Perry A KarsenDirector | 120,000 | — | — | 120,000 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 6:39 pm EST | John A. LewickiPresident | 125,000 | — | — | 125,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 7:09 pm EST | Sunil PatelSee Remarks | 100,000 | — | — | 100,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 7:08 pm EST | John A. LewickiEVP, Research & Development | 100,000 | — | — | 100,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 7:07 pm EST | Austin GurneySee Remarks | 70,000 | — | — | 70,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 7:06 pm EST | Alicia J. HagerSVP & General Counsel | 70,000 | — | — | 70,000 | — | |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:28 pm EDT | Sunil PatelSee Remarks | 50,000 | — | — | 50,000 | — | |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:28 pm EDT | John A. LewickiEVP, Research & Development | 50,000 | — | — | 50,000 | — | |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:27 pm EDT | Alicia J. HagerSVP & General Counsel | 36,666 | — | — | 36,666 | — | |
| Oct 7, 2017 AForm 4 → | Oct 10, 7:27 pm EDT | Austin GurneySee Remarks | 36,666 | — | — | 36,666 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 5:48 pm EDT | Deepika PakianathanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 5:21 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 5:20 pm EDT | Jack W LasersohnDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 5:19 pm EDT | Laurence LaskyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 5:01 pm EDT | Denise Pollard-KnightDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 4:59 pm EDT | Jonathan D RootDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 4:58 pm EDT | Rick E WinninghamDirector | 15,000 | — | — | 15,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 2, 4:54 pm EDT | Michael S WyzgaDirector | 15,000 | — | — | 15,000 | — | |
| Apr 24, 2017 AForm 4 → | Apr 25, 6:12 pm EDT | Paul J HastingsChairman & CEO, Director | 135,000 | — | — | 135,000 | — | |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:13 pm EDT | Timothy HoeySVP, Cancer Biology & Co-CSO | 60,000 | — | — | 60,000 | — | |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:12 pm EDT | Sunil PatelSee Remarks | 60,000 | — | — | 60,000 | — | |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:11 pm EDT | John A. LewickiEVP, Research & Development | 67,500 | — | — | 67,500 | — | |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:10 pm EDT | Austin GurneySee Remarks | 60,000 | — | — | 60,000 | — | |
| Apr 23, 2017 AForm 4 → | Apr 25, 6:09 pm EDT | Alicia J. HagerSVP & General Counsel | 60,000 | — | — | 60,000 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 5:57 pm EDT | Alicia J. HagerSVP & General Counsel | 6,652 | — | — | 0 | — | |
| Jan 5, 2017 MForm 4 → | Jan 9, 5:55 pm EST | Paul J HastingsChairman & CEO, Director | 42,738 | — | — | 0 | — | |
| Jan 3, 2017 AMForm 4 → | Jan 5, 7:11 pm EST | John A. LewickiEVP, Research & Development | 74,175 | — | — | 65,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:10 pm EST | Alicia J. HagerSVP & General Counsel | 55,000 | — | — | 55,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:09 pm EST | Paul J HastingsChairman & CEO, Director | 176,000 | — | — | 176,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:08 pm EST | Sunil PatelSee Remarks | 65,000 | — | — | 65,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:08 pm EST | Austin GurneySee Remarks | 55,000 | — | — | 55,000 | — | |
| Jan 3, 2017 AMForm 4 → | Jan 5, 7:07 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 67,763 | — | — | 55,000 | — | |
| Nov 16, 2016 MForm 4 → | Nov 18, 6:21 pm EST | Timothy HoeySVP, Cancer Biology & Co-CSO | 12,500 | — | — | 12,763 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:54 pm EDT | Michael S WyzgaDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:53 pm EDT | Rick E WinninghamDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:49 pm EDT | Jonathan D RootDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:48 pm EDT | Denise Pollard-KnightDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:47 pm EDT | Deepika PakianathanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:46 pm EDT | Laurence LaskyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:44 pm EDT | Jack W LasersohnDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:42 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 6:40 pm EDT | Terry P GouldDirector | 15,000 | — | — | 15,000 | — | |
| Jan 11, 2016 MForm 4 → | Jan 12, 5:38 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 138,937 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 5:21 pm EST | Perry A KarsenDirector | 30,189 | — | — | 30,189 | — | |
| Dec 28, 2015 AForm 4/A → | Mar 25, 2016, 4:15 pm EDT | Paul J HastingsChief Executive Officer, Director | 170,000 | — | — | 170,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:52 pm EST | Timothy HoeySVP, Cancer Biology | 40,000 | — | — | 40,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:51 pm EST | Austin GurneySee remarks | 40,000 | — | — | 40,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:50 pm EST | Alicia J. HagerVP & General Counsel | 40,000 | — | — | 40,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:49 pm EST | Sunil PatelSVP & Chief Financial Officer | 70,000 | — | — | 70,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:49 pm EST | John A. LewickiEVP & Chief Scientific Officer | 70,000 | — | — | 70,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:48 pm EST | Jakob DupontSVP & Chief Medical Officer | 70,000 | — | — | 70,000 | — | |
| Dec 27, 2015 AForm 4 → | Dec 29, 5:47 pm EST | Paul J HastingsChief Executive Officer, Director | 170,000 | — | — | 170,000 | — | |
| Dec 10, 2015 MForm 4 → | Dec 14, 5:02 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 141,437 | — | |
| Nov 27, 2015 MForm 4 → | Dec 1, 5:19 pm EST | Alicia J. HagerVP & General Counsel | 1,800 | — | — | 6,652 | — | |
| Nov 10, 2015 MForm 4 → | Nov 12, 6:48 pm EST | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 143,937 | — | |
| Oct 27, 2015 MForm 4 → | Oct 29, 7:49 pm EDT | Alicia J. HagerVP & General Counsel | 5,400 | — | — | 8,452 | — | |
| Oct 26, 2015 MForm 4 → | Oct 27, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 5,000 | — | — | 146,437 | — | |
| Aug 10, 2015 MForm 4 → | Aug 12, 7:14 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 151,437 | — | |
| Jul 28, 2015 MForm 4 → | Jul 29, 4:57 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | — | — | 13,852 | — | |
| Jul 10, 2015 MForm 4 → | Jul 13, 5:28 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 153,937 | — | |
| Jul 6, 2015 MForm 4 → | Jul 7, 5:06 pm EDT | Jakob DupontSVP & Chief Medical Officer | 2,500 | — | — | 156,437 | — | |
| Jun 29, 2015 MForm 4 → | Jun 30, 5:17 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | — | — | 15,652 | — | |
| Jun 24, 2015 AForm 4 → | Jun 26, 6:45 pm EDT | Rick E WinninghamDirector | 30,000 | — | — | 0 | — | |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:12 pm EDT | Timothy HoeySVP, Cancer Biology | 5,000 | — | — | 25,263 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:36 pm EDT | Denise Pollard-KnightDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:33 pm EDT | Terry P GouldDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:33 pm EDT | Laurence LaskyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:32 pm EDT | Michael S WyzgaDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:32 pm EDT | Jack W LasersohnDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:31 pm EDT | Jonathan D RootDirector | 15,000 | — | — | 15,000 | — | |
| Jun 19, 2015 AForm 4 → | Jun 23, 7:30 pm EDT | Deepika PakianathanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 5:49 pm EDT | John A. LewickiEVP & Chief Scientific Officer | 17,000 | — | — | 134,423 | — | |
| May 27, 2015 MForm 4 → | May 28, 7:05 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | — | — | 17,452 | — | |
| Apr 27, 2015 MForm 4 → | Apr 29, 5:44 pm EDT | Alicia J. HagerVP & General Counsel | 1,800 | — | — | 19,252 | — | |
| Apr 27, 2015 MForm 4 → | Apr 29, 5:43 pm EDT | Timothy HoeySVP, Cancer Biology | 5,000 | — | — | 30,263 | — | |
| Apr 10, 2015 MForm 4 → | Apr 14, 3:00 pm EDT | Jakob DupontSVP & Chief Medical Officer | 1,500 | — | — | 158,937 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 3:42 pm EDT | John A. LewickiEVP & Chief Scientific Officer | 17,000 | — | — | 23,277 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 8:31 pm EDT | Sunil PatelSee Remarks | 18,000 | — | — | 101,595 | — | |
| Mar 10, 2015 MForm 4 → | Mar 12, 8:00 pm EDT | Jakob DupontSVP & Chief Medical Officer | 1,500 | — | — | 160,437 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 5:34 pm EST | Jakob DupontSVP & Chief Medical Officer | 1,500 | — | — | 161,937 | — | |
| Feb 5, 2015 MForm 4 → | Feb 9, 5:45 pm EST | Timothy HoeySVP, Cancer Biology | 7,500 | — | — | 35,263 | — | |
| Feb 2, 2015 MForm 4/A → | Feb 4, 7:26 pm EST | John A. LewickiEVP & Chief Scientific Officer | 4,000 | — | — | 40,277 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 1:34 pm EST | John A. LewickiEVP & Chief Scientific Officer | 4,000 | — | — | 40,277 | — | |
| Jan 12, 2015 MForm 4 → | Jan 14, 5:45 pm EST | Jakob DupontSVP & Chief Medical Officer | 1,500 | — | — | 163,437 | — | |
| Jan 5, 2015 MForm 4 → | Jan 7, 4:03 pm EST | Jakob DupontSVP & Chief Medical Officer | 7,500 | — | — | 164,937 | — | |
| Jan 2, 2015 MForm 4 → | Jan 5, 8:24 pm EST | John A. LewickiEVP & Chief Scientific Officer | 4,000 | — | — | 44,277 | — |